Concepedia

Jingbo Yu

JY

Statistics

Publications

13

Citations

655

H-Index

12

Active since

2010

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Wilmington University

Amgen (United States)

Anthem (United States)

Tel Aviv University

Jingbo Yu is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacy, osteoporosis, and medicine.

Publications per year

2010–2022

13

Publications

13

Risk of mortality in patients with cancer who experience febrile neutropenia

Gary H. Lyman, Shannon L. Michels, Matthew W. Reynolds et al. · Cancer · 2010 · 247 citations · Full text

Medicine, Oncology, Cancer Epidemiology +13

Clinical and economic impact of a specialty care management program among patients with multiple sclerosis: a cohort study

Hiangkiat Tan, Jingbo Yu, David Tabby et al. · Multiple Sclerosis Journal · 2010 · 74 citations · Full text

Pharmacy, Pharmacoeconomics, Cost-effectiveness Analysis +13

Costs Associated with Febrile Neutropenia in the US

Shannon L. Michels, Rich Barron, Matthew W. Reynolds et al. · PharmacoEconomics · 2012 · 66 citations

Pharmacy, Internal Medicine, Pharmacoeconomics +11

Medication adherence and fracture risk among patients on bisphosphonate therapy in a large United States health plan

Sally Wade, Jeffrey R. Curtis, Jingbo Yu et al. · Bone · 2012 · 64 citations

Pharmacy, Clinical Pharmacy, Pharmacotherapy +16

Reasons for not initiating osteoporosis therapy among a managed care population

Ankita Modi, Jingbo Yu, Susan K. Brenneman et al. · Patient Preference and Adherence · 2015 · 39 citations · Full text

Medicine, Orthopedic Surgery, Bone Metabolism +15

1–5 of 13